The new WHO-classification 2022
What remains? What is new?
The WHO book Haematolymphoid Tumours is now available as a Beta version:
MLL Munich Leukemia Laboratory
What we offer
We are interdisciplinary experts. Our goal is to provide the best leukemia diagnostics for our patients by offering a comprehensive set of methods, state-of-the-art technology and continuous development.
We empower physicians, biologists, scientists, and researchers with web-based tools that assist in variant interpretation of sequencing data in hematologic neoplasms.
We have a wealth of experience supporting clinical research from clinical trial design to post-launch diagnostics.
Through a large number of in-house scientific projects as well as national and international collaborations, we contribute to the improvement of leukemia and lymphoma diagnostics and risk stratification of patients.
Focused methods for leukemia diagnostics form the basis for a specific therapy.
Corporate film 2020
Samples received since 2005